N-[3,4-dihydroxy-16-methyl-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]-2-hydroxytetracosanamide
-
![N-[3,4-dihydroxy-16-methyl-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]-2-hydroxytetracosanamide structure](https://file.echemi.com/fileManage/upload/canonicalSmiles/20220812/95476e65dfaf4e41867f85928459dec5.png "N-[3,4-dihydroxy-16-methyl-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]-2-hydroxytetracosanamide")
N-[3,4-dihydroxy-16-methyl-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]-2-hydroxytetracosanamide
structure -
-
CAS No:
152139-44-1
-
Formula:
C49H97NO10
-
Chemical Name:
N-[3,4-dihydroxy-16-methyl-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]-2-hydroxytetracosanamide
-
Synonyms:
agelasphin 11;agelasphin-11;AGL-11;Agelasphin 11;152139-44-1;Agelasphin-11;Agl-11;DTXSID20934434;N-(1-((alpha-D-Galactopyranosyloxy)methyl)-2,3-dihydroxy-15-methylheptadecyl)-2-hydroxytetracosanamide;N-[3,4-dihydroxy-16-methyl-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]-2-hydroxytetracosanamide;N-[1-(Hexopyranosyloxy)-3,4-dihydroxy-16-methyloctadecan-2-yl]-2-hydroxytetracosanimidic acid;Tetracosanamide, N-(1-((alpha-D-galactopyranosyloxy)methyl)-2,3-dihydroxy-15-methylheptadecyl)-2-hydroxy-
-
CAS No:
N-[3,4-dihydroxy-16-methyl-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]-2-hydroxytetracosanamide Basic Attributes
860.3 g/mol
859.71124829 g/mol
Computed Properties
Molecular Weight:860.3
XLogP3:14.5
Hydrogen Bond Donor Count:8
Hydrogen Bond Acceptor Count:10
Rotatable Bond Count:42
Exact Mass:859.71124829
Monoisotopic Mass:859.71124829
Topological Polar Surface Area:189
Heavy Atom Count:60
Complexity:961
Defined Atom Stereocenter Count:5
Undefined Atom Stereocenter Count:5
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Request for Quotation